oligonucleotides targeting apolipoprotein C-III (WAVE Life Sciences/Pfizer)

N/A

Report date: 2025/03/20 09:17:32
NME

Base Information

Drug Nameoligonucleotides targeting apolipoprotein C-III (WAVE Life Sciences/Pfizer)
Drug Alias NameN/A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide
Mechanisms of ActionApolipoprotein C-III modulators
TargetsApolipoprotein C-III
Therapy Area/IndicationsMetabolic Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesWave Life Sciences Ltd
China Registration ClassN/A

Develop Information

Active CompaniesPfizer IncWave Life Sciences Ltd
Inactive CompaniesN/A
Active IndicationsMetabolic Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A